Adam Schayowitz

ZYME

Adam Schayowitz serves as officer: EVP, Head of R&D at Zymeworks Inc. (ZYME). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$357.6K

Net Position

Net Seller

$357.6K

Companies Traded

ZYME

Active Period

Oct 2026

1 total trades

Most Recent

Sell ZYME

Oct 9, 2026 · $357.6K

Adam Schayowitz's Insider Trading at Zymeworks Inc. (ZYME)

Buys

0 · $0.00

Sells

1 · $357.6K

Total Shares Bought

Total Shares Sold

13,832

ZYME Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 9, 2026	Sell	13,832	$25.85	$357.6K	23,205

Related Insiders

Mark Hollywood

officer: EVP & Chief Operating Officer

ZYMESell · Jan 13, 2026

Kenneth Galbraith

director, officer: Chair & CEO

ZYMESell · Jan 12, 2026

Paul Andrew Moore

officer: Chief Scientific Officer

ZYMESell · Jan 12, 2026

Jeffrey T L Smith

officer: EVP & Chief Medical Officer

ZYMESell · Jan 12, 2026

Explore More Insider Trading Data

ZYME Insider Trading Activity

View all insider trades at Zymeworks Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity